Australia markets closed

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5800+0.0100 (+0.64%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
13,770
14,238
9,975
10,217
8,561
-
Cost of revenue
5,456
5,833
5,244
4,584
3,648
-
Gross profit
8,314
8,405
4,731
5,633
4,913
-
Operating expenses
Research development
879
873
1,255
1,498
2,759
-
Selling general and administrative
8,631
8,911
7,593
7,195
6,466
-
Total operating expenses
9,683
9,998
9,066
8,885
9,417
-
Operating income or loss
-1,369
-1,593
-4,335
-3,252
-4,504
-
Interest expense
2
2
20
41
110
-
Total other income/expenses net
-8
-44
64
499
77
-
Income before tax
-1,294
-1,575
-4,277
-2,784
-4,526
-
Income tax expense
-
-
-
-
0
-225
Income from continuing operations
-1,294
-1,575
-4,277
-2,784
-4,526
-
Net income
-1,294
-1,575
-7,382
-4,107
-4,766
-
Net income available to common shareholders
-1,294
-1,575
-7,382
-4,107
-4,766
-
Basic EPS
-0.21
-0.15
-0.70
-0.41
-0.52
-
Diluted EPS
-0.21
-0.15
-0.70
-0.41
-0.52
-
Basic average shares
10,353
10,386
10,297
10,018
9,079
-
Diluted average shares
10,353
10,386
10,297
10,018
9,079
-